In human cancer cells, mTOR is frequently activated and alters the activities of downstream targets, such as S6 kinases (S6K) and 4E-binding proteins (Alessi et al, 1997; Saxton and Sabatini, 2017; Zhang et al, 2017). This evidence concerns the gene MTOR and cancer.